Hypervision Surgical Receives €7.5 Million Investment

Hypervision Surgical, a London-based startup, has received €7.5 million in investment to build a surgical imaging platform. Hypervision Surgical led the financing round by a syndicate of experienced European and American HealthTech investors including HERAN Partners, Redalpine, LifeX Ventures and ZEISS Ventures, the corporate venture arm of ZEISS Group, a global technology leader in optics.

Also See: Naşide Gözde Durmuş: Separated Cancer Cells from Blood and Developed a Chip

Hypervision Surgical Aims to Create a Surgical Imaging Platform

The funding will be used to accelerate the development of Hypervision Surgical's technology and obtain regulatory clearances in the United States and Europe. The company will expand collaborations with leading surgeons, renowned surgical centers and strategic industry partners for a successful market launch and seamless integration into clinical practice. Furthermore, the completion of clinical evaluation studies in the UK in colorectal and neurosurgery next year will further strengthen the evidence base. Along with the financing announcement, Hypervision Surgical announced Martin Frost CBE, Founder and former CEO of CMR Surgical, to its board of directors.